Facultad de Medicina (FM)
Centro académico
Baylor College of Medicine
Houston, Estados UnidosPublicacions en col·laboració amb investigadors/es de Baylor College of Medicine (27)
2024
-
AI is a viable alternative to high throughput screening: a 318-target study
Scientific Reports, Vol. 14, Núm. 1
-
Locoregional Breast Cancer Recurrence in the European Organisation for Research and Treatment of Cancer 10041/BIG 03-04 MINDACT Trial: Analysis of Risk Factors Including the 70-Gene Signature
Journal of Clinical Oncology, Vol. 42, Núm. 10, pp. 1124-1134
2023
-
Correction: “The 5th edition of The World Health Organization Classification of Haematolymphoid Tumours: Lymphoid Neoplasms” Leukemia. 2022 Jul;36(7):1720–1748 (Leukemia, (2022), 36, 7, (1720-1748), 10.1038/s41375-022-01620-2)
Leukemia
-
Design and methodological considerations for biomarker discovery and validation in the Integrative Analysis of Lung Cancer Etiology and Risk (INTEGRAL) Program
Annals of Epidemiology, Vol. 77, pp. 1-12
-
Neurocognitive outcomes in pediatric brain tumors after treatment with proton versus photon radiation: a systematic review and meta-analysis
World Journal of Pediatrics, Vol. 19, Núm. 8, pp. 727-740
-
Protein Biomarkers of New-Onset Heart Failure: Insights From the Heart Omics and Ageing Cohort, the Atherosclerosis Risk in Communities Study, and the Framingham Heart Study
Circulation: Heart Failure, Vol. 16, Núm. 5, pp. E009694
2022
-
Comorbidities and mortality risk in adults younger than 50 years of age with chronic obstructive pulmonary disease
Respiratory Research, Vol. 23, Núm. 1
-
Definition and Diagnostic Criteria for Sarcopenic Obesity: ESPEN and EASO Consensus Statement
Obesity Facts, Vol. 15, Núm. 3, pp. 321-335
-
Definition and diagnostic criteria for sarcopenic obesity: ESPEN and EASO consensus statement
Clinical Nutrition, Vol. 41, Núm. 4, pp. 990-1000
-
Immunogenomic classification of hepatocellular carcinoma patients for immune check-point inhibitors therapy: Cui bono ?
Gut
-
Lung Spatial Profiling Reveals a T Cell Signature in COPD Patients with Fatal SARS-CoV-2 Infection
Cells, Vol. 11, Núm. 12
-
Similar programmed death ligand 1 (PD-L1) expression profile in patients with mild COPD and lung cancer
Scientific Reports, Vol. 12, Núm. 1
2021
-
70-gene signature as an aid for treatment decisions in early breast cancer: updated results of the phase 3 randomised MINDACT trial with an exploratory analysis by age
The Lancet Oncology, Vol. 22, Núm. 4, pp. 476-488
-
Guidelines for the use and interpretation of assays for monitoring autophagy (4th edition)1
Autophagy, Vol. 17, Núm. 1, pp. 1-382
2020
-
Standard anthracycline based versus docetaxel-capecitabine in early high clinical and/or genomic risk breast cancer in the EORTC 10041/BIG 3-04 MINDACT phase III trial
Journal of Clinical Oncology, Vol. 38, Núm. 11, pp. 1186-1197
2019
-
The oncolytic virus Delta-24-RGD elicits an antitumor effect in pediatric glioma and DIPG mouse models
Nature Communications, Vol. 10, Núm. 1
2018
-
Congenital Uterine Malformation by Experts (CUME): better criteria for distinguishing between normal/arcuate and septate uterus?
Ultrasound in Obstetrics and Gynecology, Vol. 51, Núm. 1, pp. 101-109
-
The aberrant splicing of BAF45d links splicing regulation and transcription in glioblastoma
Neuro-Oncology, Vol. 20, Núm. 7, pp. 930-941
-
Treatable inherited rare movement disorders
Movement Disorders, Vol. 33, Núm. 1, pp. 21-35
2016
-
A genomic approach to therapeutic target validation identifies a glucose-lowering GLP1R variant protective for coronary heart disease
Science Translational Medicine, Vol. 8, Núm. 341